Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA1 | P00915 | 15/20 | 0.67 |
| ▸ | CA2 | P00918 | 15/20 | 0.67 |
| ▸ | CA9 | Q16790 | 13/20 | 0.67 |
| ▸ | CA12 | O43570 | 4/20 | 0.67 |
| ▸ | CA7 | P43166 | 4/20 | 0.67 |
| ▸ | CA14 | Q9ULX7 | 4/20 | 0.67 |
| ▸ | CA3 | P07451 | 3/20 | 0.67 |
| ▸ | CA4 | P22748 | 3/20 | 0.67 |
| ▸ | CA6 | P23280 | 3/20 | 0.67 |
| ▸ | CA5A | P35218 | 3/20 | 0.67 |
| ▸ | CA5B | Q9Y2D0 | 3/20 | 0.67 |
| ▸ | RECQL | P46063 | 2/20 | 0.64 |
| ▸ | TSHR | P16473 | 2/20 | 0.64 |
| ▸ | GLA | P06280 | 1/20 | 0.64 |
| ▸ | HPGD | P15428 | 1/20 | 0.64 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.64 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.64 |
| ▸ | BLM | P54132 | 1/20 | 0.64 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.48 |
| ▸ | USP2 | O75604 | 1/20 | 0.48 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL148280 | 1.00 | CA1 (0.67) | CA1CA2CA9CA12CA7 | |
| SCHEMBL3354 | 1.00 | CA1 (0.67) | CA1CA2CA9CA12CA7 | |
| SCHEMBL41458 | 1.00 | CA1 (0.67) | CA1CA2CA9CA12CA7 | |
| SCHEMBL17336090 | 1.00 | CA1 (0.67) | CA1CA2CA9CA12CA7 | |
| SCHEMBL474049 | 1.00 | CA1 (0.67) | CA1CA2CA9CA12CA7 | |
| SCHEMBL771183 | 1.00 | CA1 (0.67) | CA1CA2CA9CA12CA7 | |
| SCHEMBL2494632 | 1.00 | CA1 (0.67) | CA1CA2CA9CA12CA7 | |
| SCHEMBL42396 | 1.00 | CA1 (0.67) | CA1CA2CA9CA12CA7 | |
| SCHEMBL147679 | 1.00 | CA1 (0.67) | CA1CA2CA9CA12CA7 | |
| SCHEMBL5199618 | 1.00 | CA1 (0.67) | CA1CA2CA9CA12CA7 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 23 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20120058067-A1 | COMPOSITIONS FOR TREATING KERATIN-CONTAINING FIBERS AND MAINTAINING DYED FIBER COLOR INTEGRITY | Kelly Van Gogh, LLC | 2012-03-08 | — | — | US | claimed |
| US-20240192100-A1 | METHOD FOR TREATING BIOLOGICAL SAMPLE | FUJIREBIO INC. (JP) | 2024-06-13 | — | — | US | disclosed |
| EP-4317451-A1 | METHOD FOR TREATING BIOLOGICAL SAMPLE | Fujirebio Inc. (JP) | 2024-02-07 | — | — | EP | disclosed |
| WO-2022211084-A1 | METHOD FOR TREATING BIOLOGICAL SAMPLE | 富士レビオ株式会社 | 2022-10-06 | — | — | WO | disclosed |
| US-20220192994-A1 | SOFTGEL FILL MATERIAL | BARLEAN'S ORGANIC OILS, LLC (US) | 2022-06-23 | — | — | US | disclosed |
| WO-2021050697-A1 | SOFTGEL FILL MATERIALS | BARLEAN'S ORGANIC OILS, LLC (US) | 2021-03-18 | — | — | WO | disclosed |
| US-20200384007-A1 | LIPID NANOPARTICLES CONTAINING PHARMACEUTICAL AND/OR NUTRACEUTICAL AGENTS AND METHODS THEREOF | BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM | 2020-12-10 | — | — | US | disclosed |
| WO-2020247912-A1 | LIPID NANOPARTICLES CONTAINING PHARMACEUTICAL AND/OR NUTRACEUTICAL AGENTS AND METHODS THEREOF | BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM (US) | 2020-12-10 | — | — | WO | disclosed |
| US-10835491-B2 | Emulsified fatty acids | BARLEAN'S ORGANIC OILS, LLC (US) | 2020-11-17 | — | — | US | disclosed |
| US-10813883-B2 | Emulsified fatty acids | BARLEAN'S ORGANIC OILS, LLC (US) | 2020-10-27 | — | — | US | disclosed |
| US-10117832-B2 | Emulsified fatty acids | BARLEAN'S ORGANIC OILS, LLC (US) | 2018-11-06 | — | — | US | disclosed |
| WO-2018118995-A1 | EMULSIFIED FATTY ACIDS | BARLEAN'S ORGANIC OILS, LLC (US) | 2018-06-28 | — | — | WO | disclosed |
| US-20180169011-A1 | EMULSIFIED FATTY ACIDS | BARLEAN'S ORGANIC OILS, LLC (US) | 2018-06-21 | — | — | US | disclosed |
| US-20130149271-A1 | COMPOSITIONS FOR REPAIRING AND RESTORING KERATIN-CONTAINING FIBERS | Kelly Van Gogh (US) | 2013-06-13 | — | — | US | disclosed |
| US-8318143-B2 | Compositions for treating keratin-containing fibers and maintaining dyed fiber color integrity | Kelly Van Gogh Hair Colour Cosmetics, Inc. (US) | 2012-11-27 | — | — | US | disclosed |
| US-8192506-B2 | Compositions for dyeing keratin-containing fibers | KELLY VAN GOGH, INC. (US) | 2012-06-05 | — | — | US | disclosed |
| US-20120058067-A1 | COMPOSITIONS FOR TREATING KERATIN-CONTAINING FIBERS AND MAINTAINING DYED FIBER COLOR INTEGRITY | Kelly Van Gogh, LLC | 2012-03-08 | — | — | US | disclosed |
| US-20120055840-A1 | COMPOSITIONS FOR DYEING KERATIN-CONTAINING FIBERS | KELLY VAN GOGH, INC. | 2012-03-08 | — | — | US | disclosed |
| US-20120058068-A1 | COMPOSITIONS FOR REPAIRING AND RESTORING KERATIN-CONTAINING FIBERS | KELLY VAN GOGH. LLC | 2012-03-08 | — | — | US | disclosed |
| US-8052762-B1 | Compositions for dyeing keratin-containing fibers | Kelly Van Gogh, LLC (US) | 2011-11-08 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (10 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20200384007-A1 | LIPID NANOPARTICLES CONTAINING PHARMACEUTICAL AND/OR NUTRACEUTICAL AGENTS AND METHODS THEREOF | GSTO1, LIPC, PHOSPHO1 | CA1 3996/4885CA2 4279/4885CA9 2251/4885 |
| US-20220192994-A1 | SOFTGEL FILL MATERIAL | LIPA, MGLL, PNLIP | CA1 4765/4885CA2 4730/4885CA9 3761/4885 |
| US-20120058068-A1 | COMPOSITIONS FOR REPAIRING AND RESTORING KERATIN-CONTAINING FIBERS | KRT18, COL14A1, COL2A1 | CA1 3888/4885CA2 4597/4885CA9 4187/4885 |
| US-20120055840-A1 | COMPOSITIONS FOR DYEING KERATIN-CONTAINING FIBERS | KRT18, JUP, CKAP4 | CA1 1998/4885CA2 2930/4885CA9 1368/4885 |
| US-10813883-B2 | Emulsified fatty acids | ELOVL1, LIPA, ELOVL3 | CA1 4790/4885CA2 4612/4885CA9 4309/4885 |
| US-10117832-B2 | Emulsified fatty acids | ELOVL1, LIPA, ELOVL3 | CA1 4790/4885CA2 4612/4885CA9 4309/4885 |
| US-20130149271-A1 | COMPOSITIONS FOR REPAIRING AND RESTORING KERATIN-CONTAINING FIBERS | KRT18, COL14A1, COL2A1 | CA1 3888/4885CA2 4597/4885CA9 4187/4885 |
| US-20120058067-A1 | COMPOSITIONS FOR TREATING KERATIN-CONTAINING FIBERS AND MAINTAINING DYED FIBER COLOR INTEGRITY | KRT18, COL1A1, COL14A1 | CA1 1827/4885CA2 3147/4885CA9 3633/4885 |
| US-20180169011-A1 | EMULSIFIED FATTY ACIDS | ELOVL1, LIPA, ELOVL3 | CA1 4790/4885CA2 4612/4885CA9 4309/4885 |
| US-10835491-B2 | Emulsified fatty acids | ELOVL1, LIPA, ELOVL3 | CA1 4790/4885CA2 4612/4885CA9 4309/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.